The Global Syndromic Multiplex Diagnostics Market was valued at approximately USD 2.81 billion in 2023 and is anticipated to grow at a CAGR of 3.91% over the forecast period 2024-2032. The increasing demand for rapid and accurate diagnostics, advancements in molecular diagnostic technologies, and the rising prevalence of infectious diseases are among the key factors driving market growth. The widespread occurrence of diseases such as respiratory infections, gastrointestinal diseases, and sexually transmitted infections (STIs) has fueled the demand for syndromic testing. According to the World Health Organization (WHO), in 2023, tuberculosis (TB) caused 1.25 million deaths, with an estimated 10.8 million people developing TB, affecting men, women, and children worldwide. This increasing burden of infectious diseases is significantly boosting the demand for effective diagnostic solutions, driving the growth of the syndromic multiplex diagnostics market.
Advancements in molecular diagnostics have played a crucial role in market expansion. Technologies such as next-generation sequencing (NGS) and advanced polymerase chain reaction (PCR) assays have significantly improved the sensitivity and specificity of syndromic multiplex diagnostics. For example, in September 2024, Roche launched the Cobas Respiratory Flex test, a novel syndromic multiplex PCR assay that can identify up to 15 respiratory pathogens from a single patient sample. This test enhances diagnostic efficiency, provides rapid results, and eliminates the need for multiple tests, ultimately streamlining laboratory workflows and improving patient care.
Moreover, increased investments in research and development (R&D) by market players are further fueling innovation. In September 2024, Seegene partnered with Springer Nature to offer research grants aimed at advancing syndromic PCR diagnostic assays. This initiative focuses on enhancing innovation in molecular diagnostics, encouraging new methodologies and the development of assays for emerging pathogens and mutations. The growing emphasis on diagnostic capabilities for infectious diseases highlights the importance of syndromic multiplex diagnostics in public health advancements.
From a geographical perspective, North America holds the largest market share due to the high prevalence of infectious diseases, strong presence of key market players, and stringent regulatory standards ensuring the adoption of effective diagnostic solutions. Europe is also a significant market, driven by technological advancements and an aging population that is highly susceptible to infections. Meanwhile, Asia-Pacific is expected to witness the fastest growth, particularly in China, India, and Japan, due to developing healthcare infrastructure and growing investments in diagnostic technologies.
Major Market Players Included in This Report Are:
• Abbott Laboratories
• Thermo Fisher Scientific, Inc.
• F. Hoffmann-La Roche Ltd
• Qiagen
• bioMérieux
• DiaSorin S.p.A (Luminex Corporation)
• Hologic, Inc.
• Becton, Dickinson and Company (BD)
• Applied BioCode
• QIAGEN
• Curetis GmbH
• QuidelOrtho Corporation
• Cepheid
• Randox Laboratories
• Seegene
The Detailed Segments and Sub-Segments of the Market Are Explained Below:
By Type
• Respiratory
• Gastrointestinal
• Central Nervous System
• Other Types of Syndromes (cUTI and STDs)
By End Use
• Hospitals
• Diagnostic Laboratories
• Others
By Region:
North America
• U.S.
• Canada
• Mexico
Europe
• UK
• Germany
• France
• Italy
• Spain
• Sweden
• Denmark
• Norway
Asia Pacific
• Japan
• China
• India
• Australia
• South Korea
• Thailand
Latin America
• Brazil
• Argentina
Middle East & Africa
• Saudi Arabia
• South Africa
• UAE
• Kuwait
Years Considered for the Study Are As Follows:
• Historical Year: 2022
• Base Year: 2023
• Forecast Period: 2024 to 2032
Key Takeaways:
• Market Estimates & Forecast for 10 Years (2022-2032)
• Annualized Revenue and Regional Analysis for Each Market Segment
• Geographical Landscape with Country-Level Analysis for Major Regions
• Competitive Landscape with Key Market Players
• Analysis of Key Business Strategies and Recommendations for Market Approach
• Demand-Side and Supply-Side Market Analysis
Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.
In this report,
Search for an exact word or phrase by placing the word or phrase in quotation marks ("market trend"). Search for different versions or tenses of a word by placing an asterisk at the end of the word (pharma*).
Please note that your term must be at least three characters long and numbers will be blocked by the # sign.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook